Erik Harris - 03 Feb 2022 Form 3 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
03 Feb 2022
Net transactions value
$0
Form type
3
Filing time
07 Feb 2022, 17:51:11 UTC
Previous filing
18 Oct 2021
Next filing
14 Feb 2022

No securities are beneficially owned.